HEALTHCARE BIOTECH – Europabio

02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.

28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.

23/11/2022

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology.

11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

24/10/2022

European Biotech Week 2022: Bringing Biotech to Local Communities

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

06/10/2022

EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology

21/09/2022

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

27/07/2022

EuropaBio presents EFIB Vilnius Statement to European policymakers

The time to act is now! Biotechnology for global transformation

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

European Biotech Week 2022: Bringing Biotech to Local Communities

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

EuropaBio celebrates its inaugural Healthcare BioForum

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe

European Biotech Week 2022 starts today!

EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology

Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

Registration is open to the main events of the 10th edition of the European Biotech Week

Advanced therapy medicinal products: SMEs call for a better investment environment in Europe

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

Factsheet – European Health Data Space

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

EuropaBio position on the European Health Data Space proposal